The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Recent progress in pancreatic cancer
Open accessAbstract
Answer questions and earn CME/CNE Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer. CA Cancer J Clin 2013;63:318‐348. © 2013 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationMoore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Self-citationEverolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., Beger, H., Fernandez-Cruz, L., Dervenis, C., Lacaine, F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032295 · Cited by 2,716
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., Schramm, H., Fahlke, J., Zuelke, C., Burkart, C., et al. (2007) · JAMA · doi:10.1001/jama.297.3.267 · Cited by 2,419
DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
Self-citationProvenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
Self-citationCD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene
Whitcomb, D. C., Gorry, M. C., Preston, R. A., Furey, W., Sossenheimer, M. J., Ulrich, C. D., Martin, S. P., Gates, L. K., Amann, S. T., Toskes, P. P., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-141 · Cited by 1,628
Gillen, S., Schuster, T., Meyer zum Büschenfelde, C., Friess, H., & Kleeff, J. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000267 · Cited by 1,552
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,489
Self-citationResected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
Sohn, T. A., Yeo, C. J., Cameron, J. L., Koniaris, L., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., & Lillemoe, K. D. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80105-5 · Cited by 1,485
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
Pancreatic Cancer: Adjuvant Combined Radiation and Chemotherapy Following Curative Resection
Kaiser, M. H. (1985) · Archives of Surgery · doi:10.1001/archsurg.1985.01390320023003 · Cited by 1,406
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., Padbury, R., Moore, M. J., Gallinger, S., Mariette, C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1275 · Cited by 1,397
American Joint Committee On Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88443-1 · Cited by 1,386
Klinkenbijl, J. H., Jeekel, J., Sahmoud, T., van Pel, R., Couvreur, M. L., Veenhof, C. H., Arnaud, J. P., Gonzalez, D. G., de Wit, L. T., Hennipman, A., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00006 · Cited by 1,286
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Jacobetz, M. A., Chan, D. S., Neesse, A., Bapiro, T. E., Cook, N., Frese, K. K., Feig, C., Nakagawa, T., Caldwell, M. E., Zecchini, H. I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302529 · Cited by 1,120
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,099
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., et al. (2011) · Science · doi:10.1126/science.1207313 · Cited by 1,083
Self-citationIacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., Vilardell, F., Wang, Z., Keller, J. W., Banerjee, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7188 · Cited by 1,081
Self-citationVon Hoff, D. D., Ramanathan, R. K., Borad, M. J., Laheru, D. A., Smith, L. S., Wood, T. E., Korn, R. L., Desai, N., Trieu, V., Iglesias, J. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.5742 · Cited by 1,044
Self-citationWitt, H., Luck, W., Hennies, H. C., Claßen, M., Kage, A., Laß, U., Landt, O., & Becker, M. (2000) · Nature Genetics · doi:10.1038/76088 · Cited by 1,034
Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
Krueger, D. A., Care, M. M., Holland, K., Agricola, K., Tudor, C., Mangeshkar, P., Wilson, K. A., Byars, A., Sahmoud, T., & Franz, D. N. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001671 · Cited by 1,006
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Prevalence of Unsuspected Pancreatic Cysts on MDCT
Laffan, T. A., Horton, K. M., Klein, A. P., Berlanstein, B., Siegelman, S. S., Kawamoto, S., Johnson, P. T., Fishman, E. K., & Hruban, R. H. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.3340 · Cited by 878
Self-citationIncreased Risk of Cancer in the Peutz–Jeghers Syndrome
Giardiello, F. M., Welsh, S. B., Hamilton, S. R., Offerhaus, G. J. A., Gittelsohn, A. M., Booker, S. V., Krush, A. J., Yardley, J. H., & Luk, G. D. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162404 · Cited by 848
Kindler, H. L., Niedzwiecki, D., Hollis, D., Sutherland, S., Schrag, D., Hurwitz, H., Innocenti, F., Mulcahy, M. F., O'Reilly, E., Wozniak, T. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1386 · Cited by 845
Loehrer, P. J., Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., Flynn, P., Ramanathan, R. K., Crane, C. H., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8904 · Cited by 830
Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease
Katz, M. H. G., Pisters, P. W. T., Evans, D. B., Sun, C. C., Lee, J. E., Fleming, J. B., Vauthey, N. J., Abdalla, E. K., Crane, C. H., Wolff, R. A., et al. (2008) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2007.12.020 · Cited by 827
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 1×
“PALB2 in familial pancreatic cancer kindreds was made by Jones et al using a whole-exome sequencing approach.(30) Subsequent studies have replicated this finding.”
MethodSelf-citationCunningham, D., Chau, I., Stocken, D. D., Valle, J. W., Smith, D., Steward, W., Harper, P. G., Dunn, J., Tudur-Smith, C., West, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2446 · Cited by 823
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784 · cited 2×
“Quantifying risk is important for the design of clinical trials to screen at-risk patients for early curable precancerous lesions.(18,19) Second, all of these genes, with the exception of those associated with familial pancreatitis, not only increase the risk of pancreatic cancer, but they also increase the risk of ex…”
BackgroundSelf-citationRecurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development
Wu, J., Matthaei, H., Maitra, A., Dal Molin, M., Wood, L. D., Eshleman, J. R., Goggins, M., Canto, M. I., Schulick, R. D., Edil, B. H., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 782
Self-citationRegine, W. F., Winter, K. A., Abrams, R. A., Safran, H., Hoffman, J. P., Konski, A., Benson, A. B., Macdonald, J. S., Kudrimoti, M. R., Fromm, M. L., et al. (2008) · JAMA · doi:10.1001/jama.299.9.1019 · Cited by 755
Smith, T. J., Staats, P. S., Deer, T., Stearns, L. J., Rauck, R. L., Boortz-Marx, R. L., Buchser, E., Català, E., Bryce, D. A., Coyne, P. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.118 · Cited by 736
Evans, D. B., Varadhachary, G. R., Crane, C. H., Sun, C. C., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Wang, H., Cleary, K. R., Staerkel, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8634 · Cited by 731
Macropinocytosis: an endocytic pathway for internalising large gulps
Lim, J. P., & Gleeson, P. A. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2011.20 · Cited by 715
Gastrointestinal Tumor Study Group (1987) · Cancer · doi:10.1002/1097-0142(19870615)59:12<2006::aid-cncr2820591206>3.0.co;2-b · Cited by 714
Heinemann, V., Quietzsch, D., Gieseler, F., Gonnermann, M., Schönekäs, H., Rost, A., Neuhaus, H., Haag, C., Clemens, M., Heinrich, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1490 · Cited by 683
Hruban, R. H., van Mansfeld, A. D. M., Offerhaus, G. J. A., van Weering, D. H. J., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K., Cameron, J. L., & Bos, J. L. (1993) · PubMed Central · Cited by 650
Self-citationFrequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648
Self-citationGermline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins, M., Schutte, M. E. M., Lü, J., Moskaluk, C. A., Weinstein, C. L., Petersen, G. M., Yeo, C. J., Jackson, C. E., Lynch, H. T., Hruban, R. H., et al. (1996) · PubMed · Cited by 642
Self-citationWu, J., Jiao, Y., Dal Molin, M., Maitra, A., de Wilde, R. F., Wood, L. D., Eshleman, J. R., Goggins, M. G., Wolfgang, C. L., Canto, M. I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118046108 · Cited by 640
Self-citationPhilip, P. A., Benedetti, J., Corless, C. L., Wong, R., O'Reilly, E. M., Flynn, P. J., Rowland, K. M., Atkins, J. N., Mirtsching, B. C., Rivkin, S. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7550 · Cited by 632
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Petersen, G. M., Amundadottir, L., Fuchs, C. S., Kraft, P., Stolzenberg-Solomon, R. Z., Jacobs, K. B., Arslan, A. A., Bueno-de-Mesquita, H. B., Gallinger, S., Gross, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.522 · Cited by 596
Self-citationRocha Lima, C. M., Green, M. R., Rotche, R., Miller, W. H., Jeffrey, G. M., Cisar, L. A., Morganti, A., Orlando, N., Gruia, G., & Miller, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.082 · Cited by 588
Argani, P., Iacobuzio–Donahue, C. A., Ryu, B., Rosty, C., Goggins, M., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Jaffee, E. M., Yeo, C. J., et al. (2001) · PubMed · Cited by 574
Self-citationPancreaticoduodenectomy with vascular resection: margin status and survival duration
Tseng, J. F., Raut, C. P., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Abdalla, E. K., Gomez, H. F., Sun, C. C., Crane, C. H., Wolff, R. A., et al. (2004) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2004.09.046 · Cited by 557
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
van Lier, M. G. F., Wagner, A., Mathus-Vliegen, E. M. H., Kuipers, E. J., Steyerberg, E. W., & van Leerdam, M. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.725 · Cited by 542
The genetics of hereditary colon cancer
Rustgi, A. K. (2007) · Genes & Development · doi:10.1101/gad.1593107 · Cited by 529
Huguet, F., André, T., Hammel, P., Artru, P., Balosso, J., Selle, F., Deniaud-Alexandre, E., Ruszniewski, P., Touboul, E., Labianca, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.5663 · Cited by 529
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study
Canto, M. I., Goggins, M., Hruban, R. H., Petersen, G. M., Giardiello, F. M., Yeo, C., Fishman, E. K., Brune, K., Axilbund, J., Griffin, C., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.005 · Cited by 524
Self-citationTempero, M., Plunkett, W., Ruiz van Haperen, V., Hainsworth, J., Hochster, H., Lenzi, R., & Abbruzzese, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.140 · Cited by 519
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
Wong, G. Y., Schroeder, D. R., Carns, P. E., Wilson, J. L., Martin, D. P., Kinney, M. O., Mantilla, C. B., & Warner, D. O. (2004) · JAMA · doi:10.1001/jama.291.9.1092 · Cited by 506
Venkat, R., Edil, B. H., Schulick, R. D., Lidor, A. O., Makary, M. A., & Wolfgang, C. L. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318251ee09 · Cited by 502
Self-citationATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491 · cited 2×
“They include MLL3, TGFBR2, FBXW7, ARID1A, AIRID2, and ATM.79,87 ATM is particularly interesting because it is a possible therapeutic target as cancers which have genetically inactivated ATM may be particularly sensitive to radiation damage and to poly(ADP) ribose polymerase (PARP) inhibitors.88 In addition to changes…”
BackgroundSelf-citationVaradhachary, G. R., Wolff, R. A., Crane, C. H., Sun, C. C., Lee, J. E., Pisters, P. W. T., Vauthey, J.-N., Abdalla, E., Wang, H., Staerkel, G. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8642 · Cited by 466
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2551 · Cited by 442
Hassan, R., Bera, T., & Pastan, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0801 · Cited by 441
Poplin, E., Feng, Y., Berlin, J., Rothenberg, M. L., Hochster, H., Mitchell, E., Alberts, S., O'Dwyer, P., Haller, D., Catalano, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9007 · Cited by 438
Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435
Self-citationHeinemann, V., Boeck, S., Hinke, A., Labianca, R., & Louvet, C. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-82 · Cited by 434
Bosetti, C., Lucenteforte, E., Silverman, D. T., Petersen, G., Bracci, P. M., Ji, B. T., Negri, E., Li, D., Risch, H. A., Olson, S. H., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr541 · Cited by 411
Infante, J. R., Matsubayashi, H., Sato, N., Tonascia, J., Klein, A. P., Riall, T. A., Yeo, C., Iacobuzio-Donahue, C., & Goggins, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.8824 · Cited by 406
Self-citationEric, L., Yeo, C. J., Lillemoe, K. D., Biedrzycki, B., Kobrin, B., Herman, J., Sugar, E., Piantadosi, S., Cameron, J. L., Solt, S., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e3181fd271c · Cited by 403
Self-citationABO Blood Group and the Risk of Pancreatic Cancer
Wolpin, B. M., Chan, A. T., Hartge, P., Chanock, S. J., Kraft, P., Hunter, D. J., Giovannucci, E. L., & Fuchs, C. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp020 · Cited by 395
Herman, J. M., Swartz, M. J., Hsu, C. C., Winter, J., Pawlik, T. M., Sugar, E., Robinson, R., Laheru, D. A., Jaffee, E., Hruban, R. H., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8469 · Cited by 375
Self-citationSMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Blackford, A., Serrano, O. K., Wolfgang, C. L., Parmigiani, G., Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Eshleman, J. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0227 · Cited by 371
Self-citationHruban, R. H., Pitman, M. B., & Klimstra, D. S. (2007) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/9781933477022 · Cited by 370
Self-citationPelzer, U., Schwaner, I., Stieler, J., Adler, M., Seraphin, J., Dörken, B., Riess, H., & Oettle, H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.011 · Cited by 370
Arslan, A. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.63 · Cited by 363
Total Laparoscopic Pancreaticoduodenectomy: Feasibility and Outcome in an Early Experience
Kendrick, M. L., & Cusati, D. (2010) · Archives of Surgery · doi:10.1001/archsurg.2009.243 · Cited by 352
(2006) · PubMed · Cited by 347
Vasen, H. F. A., Gruis, N. A., Frants, R. R., van der Velden, P. A., Hille, E. T. M., & Bergman, W. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000915)87:6<809::aid-ijc8>3.0.co;2-u · Cited by 347
Cigarette Smoking as a Risk Factor for Pancreatic Cancer in Patients With Hereditary Pancreatitis
Lowenfels, A. B. (2001) · JAMA · doi:10.1001/jama.286.2.169 · Cited by 328
Deer, T. R., Prager, J., Levy, R., Rathmell, J., Buchser, E., Burton, A., Caraway, D., Cousins, M., De Andrés, J., Diwan, S., et al. (2012) · Neuromodulation: Technology at the Neural Interface · doi:10.1111/j.1525-1403.2012.00476.x · Cited by 327
Self-citationA Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
Collisson, E. A., Trejo, C. L., Silva, J. M., Gu, S., Korkola, J. E., Heiser, L. M., Charles, R.-P., Rabinovich, B. A., Hann, B., Dankort, D., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0347 · Cited by 320
Regine, W. F., Winter, K. A., Abrams, R., Safran, H., Hoffman, J. P., Konski, A., Benson, A. B., Macdonald, J. S., Rich, T. A., & Willett, C. G. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1630-6 · Cited by 311
Oettle, H., Richards, D., Ramanathan, R. K., van Laethem, J. L., Peeters, M., Fuchs, M., Zimmermann, A., John, W., Von Hoff, D., Arning, M., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi309 · Cited by 306
Colucci, G., Labianca, R., Di Costanzo, F., Gebbia, V., Cartenì, G., Massidda, B., Dapretto, E., Manzione, L., Piazza, E., Sannicolò, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4433 · Cited by 304
Pancreatic Adenocarcinoma, Version 2.2012: Featured Updates to the NCCN Guidelines
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., Cohen, S. J., Czito, B., Ellenhorn, J. D. I., Hawkins, W. G., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0073 · Cited by 304
Self-citationLIFE-STYLE RISK FACTORS FOR PANCREATIC CANCER IN LOUISIANA: A CASE-CONTROL STUDY
FALK, R. T., WILLIAMS PICKLE, L., FONTHAM, E. T., CORREA, P., & FRAUMENI, J. F. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114972 · Cited by 300
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia
Habbe, N., Koorstra, J.-B. M., Mendell, J. T., Offerhaus, G. J., Ryu, J. K., Feldmann, G., Mullendore, M. E., Goggins, M. G., Hong, S.-M., & Maitra, A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.4.7338 · Cited by 300
Precursors to Invasive Pancreatic Cancer
Maitra, A., Fukushima, N., Takaori, K., & Hruban, R. H. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155055.14238.25 · Cited by 291
Self-citationA Compendium of Potential Biomarkers of Pancreatic Cancer
Harsha, H. C., Kandasamy, K., Ranganathan, P., Rani, S., Ramabadran, S., Gollapudi, S., Balakrishnan, L., Dwivedi, S. B., Telikicherla, D., Selvan, L. D. N., et al. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000046 · Cited by 288
Self-citationCrane, C. H., Varadhachary, G. R., Yordy, J. S., Staerkel, G. A., Javle, M. M., Safran, H., Haque, W., Hobbs, B. D., Krishnan, S., Fleming, J. B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.8038 · Cited by 288
Genetic, Immunohistochemical, and Clinical Features of Medullary Carcinoma of the Pancreas
Wilentz, R. E., Goggins, M., Redston, M., Marcus, V. A., Adsay, N. V., Sohn, T. A., Kadkol, S. S., Yeo, C. J., Choti, M., Zahurak, M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65035-3 · Cited by 282
Self-citationAbou-Alfa, G. K., Letourneau, R., Harker, G., Modiano, M., Hurwitz, H., Tchekmedyian, N. S., Feit, K., Ackerman, J., De Jager, R. L., Eckhardt, S. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0201 · Cited by 282
PALB2 mutations in European familial pancreatic cancer families
Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01425.x · Cited by 278
Abrams, R. A., Winter, K. A., Regine, W. F., Safran, H., Hoffman, J. P., Lustig, R., Konski, A. A., Benson, A. B., Macdonald, J. S., Rich, T. A., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.11.039 · Cited by 278
Reddy, S., Cameron, J. L., Scudiere, J., Hruban, R. H., Fishman, E. K., Ahuja, N., Pawlik, T. M., Edil, B. H., Schulick, R. D., & Wolfgang, C. L. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.01.044 · Cited by 275
Self-citationThe Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Brune, K., de Andrade, M., Goggins, M., Rothenmund, H., Gallinger, S., Klein, A., Petersen, G. M., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0783 · Cited by 275
Self-citationPawlik, T. M., Laheru, D., Hruban, R. H., Coleman, J., Wolfgang, C. L., Campbell, K., Ali, S., Fishman, E. K., Schulick, R. D., Herman, J. M., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9929-7 · Cited by 273
Self-citationKrishnan, S., Rana, V., Janjan, N. A., Varadhachary, G. R., Abbruzzese, J. L., Das, P., Delclos, M. E., Gould, M. S., Evans, D. B., Wolff, R. A., et al. (2007) · Cancer · doi:10.1002/cncr.22735 · Cited by 272
Corsini, M. M., Miller, R. C., Haddock, M. G., Donohue, J. H., Farnell, M. B., Nagorney, D. M., Jatoi, A., McWilliams, R. R., Kim, G. P., Bhatia, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8782 · Cited by 270
Sato, N., Rosty, C., Jansen, M., Fukushima, N., Ueki, T., Yeo, C. J., Cameron, J. L., Iacobuzio-Donahue, C. A., Hruban, R. H., & Goggins, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63053-2 · Cited by 267
Self-citationDuell, E. J., Lucenteforte, E., Olson, S. H., Bracci, P. M., Li, D., Risch, H. A., Silverman, D. T., Ji, B. T., Gallinger, S., Holly, E. A., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds140 · Cited by 263
Picozzi, V. J., Kozarek, R. A., & Traverso, L. W. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00051-5 · Cited by 262
Importance of Age of Onset in Pancreatic Cancer Kindreds
Brune, K. A., Lau, B., Palmisano, E., Canto, M., Goggins, M. G., Hruban, R. H., & Klein, A. P. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp466 · Cited by 257
Self-citationHsu, C. C., Herman, J. M., Corsini, M. M., Winter, J. M., Callister, M. D., Haddock, M. G., Cameron, J. L., Pawlik, T. M., Schulick, R. D., Wolfgang, C. L., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0743-7 · Cited by 256
Self-citationVillarroel, M. C., Rajeshkumar, N. V., Garrido-Laguna, I., De Jesus-Acosta, A., Jones, S., Maitra, A., Hruban, R. H., Eshleman, J. R., Klein, A., Laheru, D., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0893 · Cited by 249
Self-citationResected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up
Riall, T. S., Cameron, J. L., Lillemoe, K. D., Winter, J. M., Campbell, K. A., Hruban, R. H., Chang, D., & Yeo, C. J. (2006) · Surgery · doi:10.1016/j.surg.2006.04.006 · Cited by 246
Self-citationLowery, M. A., Kelsen, D. P., Stadler, Z. K., Yu, K. H., Janjigian, Y. Y., Ludwig, E., D'Adamo, D. R., Salo-Mullen, E., Robson, M. E., Allen, P. J., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0185 · Cited by 245
Lucenteforte, E., La Vecchia, C., Silverman, D., Petersen, G. M., Bracci, P. M., Ji, B. T., Bosetti, C., Li, D., Gallinger, S., Miller, A. B., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr120 · Cited by 238
Neurolytic Celiac Plexus Block for Pain Control in Unresectable Pancreatic Cancer
Yan, B. M., & Myers, R. P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00967.x · Cited by 234
Epidemiology of Pancreatic Cancer: An Update
Maisonneuve, P., & Lowenfels, A. B. (2010) · Digestive Diseases · doi:10.1159/000320068 · Cited by 233
Poultsides, G. A., Reddy, S., Cameron, J. L., Hruban, R. H., Pawlik, T. M., Ahuja, N., Jain, A., Edil, B. H., Iacobuzio-Donahue, C. A., Schulick, R. D., et al. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cf8a19 · Cited by 226
Self-citationGermline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients
Özcelik, H., Schmocker, B., Nicola, N. D., Shi, X.-H., Langer, B., Moore, M., Taylor, B. R., Narod, S. A., Darlington, G., Andrulis, I. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-17 · Cited by 225
Shi, C., Hruban, R. H., & Klein, A. P. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.365 · Cited by 212
Self-citationChatterjee, D., Katz, M. H., Rashid, A., Wang, H., Iuga, A. C., Varadhachary, G. R., Wolff, R. A., Lee, J. E., Pisters, P. W., Crane, C. H., et al. (2012) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31824104c5 · Cited by 208
BRCA Germline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
Ferrone, C. R., Levine, D. A., Tang, L. H., Allen, P. J., Jarnagin, W., Brennan, M. F., Offit, K., & Robson, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5546 · Cited by 206
Kaelin, W. G., & Thompson, C. B. (2010) · Nature · doi:10.1038/465562a · Cited by 197
Ghadirian, P., Boyle, P., Simard, A., Baillargeon, J., Maisonneuve, P., & Perret, C. (1991) · International journal of pancreatology · doi:10.1007/bf02924156 · Cited by 193
Lepisto, A. J., Moser, A. J., Zeh, H. J., Lee, K., Bartlett, D. L., McKolanis, J., Geller, B. A., Schmotzer, A. R., Potter, D. P., Whiteside, T. L., et al. (2008) · PubMed · Cited by 189
Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.055 · Cited by 189
Ben-Josef, E., Schipper, M., Francis, I. R., Hadley, S., Ten-Haken, R., Lawrence, T., Normolle, D., Simeone, D. M., Sonnenday, C., Abrams, R., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.02.051 · Cited by 187
Heinrich, S., Pestalozzi, B. C., Schäfer, M., Weber, A., Bauerfeind, P., Knuth, A., & Clavien, P.-A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5556 · Cited by 187
Wedén, S., Klemp, M., Gladhaug, I. P., Møller, M., Eriksen, J. A., Gaudernack, G., & Buanes, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.25449 · Cited by 183
Kanda, M., Sadakari, Y., Borges, M., Topazian, M., Farrell, J., Syngal, S., Lee, J., Kamel, I., Lennon, A. M., Knight, S., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.016 · Cited by 181
Self-citationGenome-wide profiling at methylated promoters in pancreatic adenocarcinoma
Omura, N., Li, C.-P., Li, A., Hong, S.-M., Walter, K., Jimeno, A., Hidalgo, M., & Goggins, M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6208 · Cited by 177
Boyd, C. A., Benarroch-Gampel, J., Sheffield, K. M., Cooksley, C. D., & Riall, T. S. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2011.06.015 · Cited by 174
Kanda, M., Knight, S., Topazian, M., Syngal, S., Farrell, J., Lee, J., Kamel, I., Lennon, A. M., Borges, M., Young, A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302823 · Cited by 171
Self-citationMutant proteins as cancer-specific biomarkers
Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J., Papadopoulos, N., Kopelovich, L., Maitra, A., Matthaei, H., Eshleman, J. R., Hruban, R. H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019203108 · Cited by 168
Self-citationSchmidt, J., Abel, U., Debus, J., Harig, S., Hoffmann, K., Herrmann, T., Bartsch, D., Klein, J., Mansmann, U., Jäger, D., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2960 · Cited by 167
Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
Kulke, M. H., Blaszkowsky, L. S., Ryan, D. P., Clark, J. W., Meyerhardt, J. A., Zhu, A. X., Enzinger, P. C., Kwak, E. L., Muzikansky, A., Lawrence, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8521 · Cited by 166
He, J., Cameron, J. L., Ahuja, N., Makary, M. A., Hirose, K., Choti, M. A., Schulick, R. D., Hruban, R. H., Pawlik, T. M., & Wolfgang, C. L. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2012.12.026 · Cited by 164
Self-citationPancreatic fibrosis associated with age and ductal papillary hyperplasia
Detlefsen, S., Sipos, B., Feyerabend, B., & Klöppel, G. (2005) · Virchows Archiv · doi:10.1007/s00428-005-0032-1 · Cited by 161
miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts
Matthaei, H., Wylie, D., Lloyd, M. B., Molin, M. D., Kemppainen, J., Mayo, S. C., Wolfgang, C. L., Schulick, R. D., Langfield, L., Andruss, B. F., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0035 · Cited by 159
Self-citationArnaoutakis, G. J., Rangachari, D., Laheru, D. A., Iacobuzio-Donahue, C. A., Hruban, R. H., Herman, J. M., Edil, B. H., Pawlik, T. M., Schulick, R. D., Cameron, J. L., et al. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1605-8 · Cited by 158
Self-citationFamilial Risk of Pancreatic Cancer
Schenk, M., Schwartz, A. G., O'Neal, E., Kinnard, M. F., Greenson, J. K., Fryzek, J. P., Ying, G., & Garabrant, D. H. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.640 · Cited by 156
Imaging of Pancreatic Adenocarcinoma: Update on Staging/Resectability
Tamm, E. P., Balachandran, A., Bhosale, P., Katz, M. H. G., Fleming, J. B., Lee, J. H., & Varadhachary, G. R. (2012) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2012.03.008 · Cited by 154
Small, W. C., Berlin, J. D., Freedman, G. M., Lawrence, T. S., Talamonti, M. S., Mulcahy, M. F., Chakravarthy, A. B., Konski, A. A., Zalupski, M. M., Philip, P. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9014 · Cited by 154
Jacobs, E. J., Chanock, S. J., Fuchs, C. S., LaCroix, A., McWilliams, R. R., Steplowski, E., Stolzenberg‐Solomon, R. Z., Arslan, A. A., Bueno‐de‐Mesquita, H. B., Gross, M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25148 · Cited by 151
In vivoTherapeutic Responses Contingent on Fanconi Anemia/BRCA2 Status of the Tumor
van der Heijden, M. S., Brody, J. R., Dezentjé, D. A., Gallmeier, E., Cunningham, S. C., Swartz, M. J., Marzo, A. M. D., Offerhaus, G. J. A., Isacoff, W. H., Hruban, R. H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1048 · Cited by 150
Self-citationVauthey, J., & Dixon, E. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0409-5 · Cited by 149
Xiong, H. Q., Varadhachary, G. R., Blais, J. C., Hess, K. R., Abbruzzese, J. L., & Wolff, R. A. (2008) · Cancer · doi:10.1002/cncr.23810 · Cited by 143
Seidel, G. A., ZAHURAK, M. L., Iacobuzio–Donahue, C. A., Sohn, T. A., Adsay, V. N., Yeo, C. J., Lillemoe, K. D., Cameron, J. L., Hruban, R. H., & Wilentz, R. E. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200201000-00006 · Cited by 142
Self-citationLaurence, J. M., Tran, P. D., Morarji, K., Eslick, G. D., Lam, V. W. T., & Sandroussi, C. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1659-7 · Cited by 139
Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma
Huebner, M., Kendrick, M. L., Reid–Lombardo, K. M., Que, F. G., Therneau, T. M., Qin, R., Donohue, J. H., Nagorney, D. M., Farnell, M. B., & Sarr, M. G. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1853-2 · Cited by 138
Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling
McWilliams, R. R., Wieben, E. D., Rabe, K. G., Pedersen, K. S., Wu, Y., Sicotte, H., & Petersen, G. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.198 · Cited by 135
Pancreatic Intraepithelial Neoplasia Revisited and Updated
Sipos, B., Frank, S., Gress, T. M., Hahn, S. A., & Klöppel, G. (2008) · Pancreatology · doi:10.1159/000178874 · Cited by 135
Prognostic value of microsatellite instability in resectable pancreatic cancer.
Nakata, B., Wang, Y. Q., Yashiro, M., Nishioka, N., Tanaka, H., Ohira, M., Ishikawa, T., Nishino, H., & Hirakawa, K. (2002) · PubMed · Cited by 135
Crane, C. H., Winter, K. A., Regine, W. F., Safran, H. P., Rich, T. A., Curran, W. J., Wolff, R. A., & Willett, C. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.8529 · Cited by 132
Williamson, C. T., Kubota, E., Hamill, J. D., Klimowicz, A. C., Ye, R., Muzik, H., Dean, M. L., Tu, L., Gilley, D. P., Magliocco, A. M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200229 · Cited by 132
Schellenberg, D. D., Quon, A., Minn, A. Y., Graves, E. E., Kunz, P. L., Ford, J. M., Fisher, G. A., Goodman, K. A., Koong, A. C., & Chang, D. T. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.049 · Cited by 121
Korsse, S. E., Harinck, F., van Lier, M. G., Biermann, K., Offerhaus, G. J. A., Krak, N. C., Looman, C. W. N., van Veelen, W., Kuipers, E. J., Wagner, A., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101277 · Cited by 118
Genetic mutations associated with cigarette smoking in pancreatic cancer
Blackford, A., Parmigiani, G., Kensler, T. W., Wolfgang, C., Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Eshleman, J. R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0015 · Cited by 113
Self-citationKo, A. H., Quivey, J. M., Venook, A. P., Bergsland, E. K., Dito, E., Schillinger, B., & Tempero, M. A. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.005 · Cited by 107
Tumor microenvironment and progression of pancreatic cancer.
Erkan, M., Reiser–Erkan, C., Michalski, C. W., & Kleeff, J. H. (2010) · PubMed · Cited by 106
Diagnosing Pancreatic Cancer Using Methylation Specific PCR Analysis
Fukushima, N., Walter, K., Ueki, T., Sato, N., Matsubayashi, H., Cameron, J. L., Hruban, R. H., Canto, M. I., Yeo, C. J., & Goggins, M. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.183 · Cited by 106
Self-citationPicozzi, V. J., Abrams, R. A., Decker, P. A., Traverso, W. L., O'Reilly, E. M., Greeno, E. W., Martin, R. C. G., Wilfong, L. S., Rothenberg, M. L., Posner, M. C., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq384 · Cited by 104
Voong, K. R., Davison, J. M., Pawlik, T. M., Uy, M. O., Hsu, C. C.-C., Winter, J. M., Hruban, R. H., Laheru, D. A., Rudra, S., Swartz, M. J., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.07.012 · Cited by 100
Self-citationKhashab, M. A., Kim, K. J., Tryggestad, E. J., Wild, A. T., Roland, T., Singh, V. K., Lennon, A. M., Shin, E. J., Ziegler, M. A., Sharaiha, R. Z., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.07.006 · Cited by 93
Self-citationA critical role for autophagy in pancreatic cancer
Yang, S., & Kimmelman, A. C. (2011) · Autophagy · doi:10.4161/auto.7.8.15762 · Cited by 91
Kulke, M. H., Tempero, M. A., Niedzwiecki, D., Hollis, D. R., Kindler, H. L., Cusnir, M., Enzinger, P. C., Gorsch, S. M., Goldberg, R. M., & Mayer, R. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1309 · Cited by 86
Small‐Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics
Yap, J. L., Worlikar, S. A., MacKerell, A. D., Shapiro, P., & Fletcher, S. (2010) · ChemMedChem · doi:10.1002/cmdc.201000354 · Cited by 85
The effect of depression on stage at diagnosis, treatment, and survival in pancreatic adenocarcinoma
Boyd, C. A., Benarroch‐Gampel, J., Sheffield, K. M., Han, Y., Kuo, Y., & Riall, T. S. (2012) · Surgery · doi:10.1016/j.surg.2012.06.010 · Cited by 83
Missiaglia, E., Donadelli, M., Palmieri, M., Crnogorac‐Jurcevic, T., Scarpa, A., & Lemoine, N. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208018 · Cited by 83
Prospective risk of cancer in CDKN2A germline mutation carriers
Goldstein, A. M., Struewing, J. P., Fraser, M. C., Smith, M. W., & Tucker, M. A. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019349 · Cited by 82
Pancreatic cancer and depression: myth and truth
Mayr, M., & Schmid, R. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-569 · Cited by 80
Nathan, H., Wolfgang, C. L., Edil, B. H., Choti, M. A., Herman, J. M., Schulick, R. D., Cameron, J. L., & Pawlik, T. M. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21189 · Cited by 79
Self-citationDuffy, A. G., Kortmansky, J. S., Schwartz, G. K., Capanu, M., Puleio, S. A., Minsky, B. D., Saltz, L. B., O'Reilly, E. M., & Kelsen, D. P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm441 · Cited by 79
Clinical importance of precursor lesions in the pancreas
Hruban, R. H., Takaori, K., Canto, M. I., Fishman, E. K., Campbell, K. A., Brune, K. A., Kern, S. E., & Goggins, M. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1170-9 · Cited by 76
Self-citationWahl, R. L., Herman, J. M., & Ford, E. (2011) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.11.004 · Cited by 75
Self-citationErdek, M. A., Halpert, D. E., González‐Fernández, M., & Cohen, S. P. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00756.x · Cited by 71
Self-citationGenetically Defined Subsets of Human Pancreatic Cancer Show Unique In Vitro Chemosensitivity
Cui, Y., Brosnan‐Cashman, J. A., Blackford, A. L., Sur, S., Hruban, R. H., Kinzler, K. W., Vogelstein, B., Maitra, A., Diaz, L. A., Iacobuzio–Donahue, C. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0827 · Cited by 71
Self-citationShi, C., Fukushima, N., Abe, T., Bian, Y., Hua, L., Wendelburg, B. J., Yeo, C. J., Hruban, R. H., Goggins, M., & Eshleman, J. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.3.5362 · Cited by 68
Self-citationElevated Cancer Mortality in the Relatives of Patients with Pancreatic Cancer
Wang, L., Brune, K. A., Visvanathan, K., Laheru, D. A., Herman, J. M., Wolfgang, C. L., Schulick, R. D., Cameron, J. L., Goggins, M., Hruban, R. H., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0557 · Cited by 68
Self-citationThe Effectiveness of Repeat Celiac Plexus Neurolysis for Pancreatic Cancer: A Pilot Study
McGreevy, K., Hurley, R. W., Erdek, M. A., Aner, M. M., Li, S., & Cohen, S. P. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00557.x · Cited by 64
Self-citationConceptual Framework for Cutting the Pancreatic Cancer Fuel Supply
Le, A., Rajeshkumar, N. V., Maitra, A., & Dang, C. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0041 · Cited by 61
Management of Pancreatic Serous Cystadenomas
Wargo, J. A., Fernández‐del‐Castillo, C., & Warshaw, A. L. (2009) · Advances in Surgery · doi:10.1016/j.yasu.2009.03.001 · Cited by 60
Absence of germline BRCA1 mutations in familial pancreatic cancer patients
Axilbund, J. E., Argani, P., Kamiyama, M., Palmisano, E., Raben, M., Borges, M. W., Brune, K. A., Goggins, M., Hruban, R. H., & Klein, A. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.2.7136 · Cited by 58
Self-citationSmall, W. C., Mulcahy, M. F., RADEMAKER, A. W., Bentrem, D. J., Benson, A. B., Weitner, B. B., & Talamonti, M. S. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.02.030 · Cited by 56
Hsu, C. C.-C., Wolfgang, C. L., Laheru, D. A., Pawlik, T. M., Swartz, M. J., Winter, J. M., Robinson, R. E., Edil, B. H., Narang, A. K., Choti, M. A., et al. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1811-4 · Cited by 52
Self-citationGenetics of Pancreatitis: An Update for Clinicians and Genetic Counselors
Solomon, S. R., & Whitcomb, D. C. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0240-1 · Cited by 51
Jesus‐Acosta, A. D., Oliver, G. R., Blackford, A. L., Kinsman, K., Flores, E. I., Wilfong, L. S., Zheng, L., Donehower, R. C., Cosgrove, D., Laheru, D. A., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1704-y · Cited by 46
Self-citationRaymond, É., Hobday, T. J., Castellano, D., Reidy‐Lagunes, D. L., García‐Carbonero, R., & Carrato, A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9291-2 · Cited by 43
Genetics of alcoholic and nonalcoholic pancreatitis
Whitcomb, D. C. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328356e7f3 · Cited by 39
Serum CA19-9 determination in the management of pancreatic cancer.
van den Bosch, R. P., van Eijck, C. H. J., Mulder, P. G. H., & Jeekel, J. J. (1997) · PubMed · Cited by 38
Systematic review/Meta-analysis Diagnostic value of microRNA for pancreatic cancer: a meta-analysis
Wan, C., Shen, Y., Yang, T., Wang, T., Chen, L., & Wen, F. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.31609 · Cited by 38
Rutter, J. L., Bromley, C. M., Goldstein, A. M., Elder, D. E., Holly, E. A., Guerry, D., Hartge, P. A., Struewing, J. P., Hogg, D., Halpern, A. C., et al. (2004) · Cancer · doi:10.1002/cncr.20669 · Cited by 36
Siddiqui, A. A., Kowalski, T. E., Kedika, R., Roy, A., Loren, D. E., Ellsworth, E., Adler, D. G., & Finkelstein, S. D. (2013) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.11.009 · Cited by 36
(2012) · Annals of Oncology · doi:10.1093/annonc/mds491 · Cited by 34
Cited by
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019
“Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that typically presents at an advanced stage and is refractory to most treatment modalities (Ryan et al., 2014; Wolfgang et al., 2013).”
Self-citationKleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Self-citationKRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Waters, A. M., & Der, C. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031435 · Cited by 875
Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience
Kamada, T., Tsujii, H., Blakely, E. A., Debus, J., De Neve, W., Durante, M., Jäkel, O., Mayer, R., Orecchia, R., Pötter, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70412-7 · Cited by 562
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Gemenetzis, G., Groot, V. P., Blair, A. B., Laheru, D. A., Zheng, L., Narang, A. K., Fishman, E. K., Hruban, R. H., Yu, J., Burkhart, R. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002753 · Cited by 401
Self-citation
Metadata
- Authors
- Wolfgang, C. L., Herman, J. M., Laheru, D. A., Klein, A. P., Erdek, M. A., Fishman, E. K., & Hruban, R. H.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2013-07-15
- Volume
- 63
- Issue
- 5
- Pages
- 318-348
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2160391606
- Cited by
- 910
- References
- 206
- FWCI
- 32.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.